Hims & Hers' 38.4% subscriber growth and $576.4 million online revenues highlight the power of its personalized subscription model.

Hims & Hers Health Inc. shares slid over 2.8% on Tuesday and continued declining after-hours trading after Eli Lilly ...

New collaboration delivers 50% off prescription sleep support for new customers who are struggling with insomnia and sleep ...

LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of June: ...

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced a limited-time $299 introductory bundle for new self ...

LifeMD, Inc. announced its participation in several investor conferences throughout May 2025, including the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20, the B. Riley ...

LifeMD, a leader in virtual healthcare services with a market capitalization of $346.54 million, reported its Q1 2025 earnings, showcasing a strong financial performance that exceeded market ...

Hims & Hers Health, LifeMD, Ro, and other platforms like them will now be able to sell Novo Nordisk's Wegovy, which is used for weight loss. The blockbuster GLP-1 should entice customers.

LifeMD's weight management program is one of the fastest-growing cash-pay offerings in the country, delivering virtual consultations, lab testing, diet and lifestyle support, and prescriptions to ...

Telehealth company LifeMD bought assets from Optimal Human Health MD to accelerate its push into the women’s health market. The acquisition establishes a scalable clinical and operational ...